- Home
- AMBO vs CHEK Comparison
AMBO vs CHEK Comparison
Compare AMBO & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBO
- CHEK
- Stock Information
- Founded
- AMBO 2000
- CHEK 2004
- Country
- AMBO United States
- CHEK Israel
- Employees
- AMBO N/A
- CHEK N/A
- Industry
- AMBO Other Consumer Services
- CHEK Medical Electronics
- Sector
- AMBO Real Estate
- CHEK Health Care
- Exchange
- AMBO Nasdaq
- CHEK Nasdaq
- Market Cap
- AMBO 5.1M
- CHEK 5.1M
- IPO Year
- AMBO 2010
- CHEK 2015
- Fundamental
- Price
- AMBO $1.43
- CHEK $1.91
- Analyst Decision
- AMBO
- CHEK
- Analyst Count
- AMBO 0
- CHEK 0
- Target Price
- AMBO N/A
- CHEK N/A
- AVG Volume (30 Days)
- AMBO 157.1K
- CHEK 15.5K
- Earning Date
- AMBO 12-27-2024
- CHEK 02-14-2025
- Dividend Yield
- AMBO N/A
- CHEK N/A
- EPS Growth
- AMBO N/A
- CHEK N/A
- EPS
- AMBO N/A
- CHEK N/A
- Revenue
- AMBO $9,163,000.00
- CHEK N/A
- Revenue This Year
- AMBO N/A
- CHEK N/A
- Revenue Next Year
- AMBO N/A
- CHEK N/A
- P/E Ratio
- AMBO N/A
- CHEK N/A
- Revenue Growth
- AMBO N/A
- CHEK N/A
- 52 Week Low
- AMBO $1.00
- CHEK $0.56
- 52 Week High
- AMBO $6.30
- CHEK $3.45
- Technical
- Relative Strength Index (RSI)
- AMBO 40.93
- CHEK 26.97
- Support Level
- AMBO $1.35
- CHEK $0.56
- Resistance Level
- AMBO $1.56
- CHEK $0.63
- Average True Range (ATR)
- AMBO 0.18
- CHEK 0.04
- MACD
- AMBO -0.05
- CHEK 0.00
- Stochastic Oscillator
- AMBO 7.55
- CHEK 18.87
About AMBO Ambow Education Holding Ltd.
Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.